Analyst Reco. PROCEPT BioRobotics Corporation

Equities

PRCT

US74276L1052

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
66.4 ^USD	+3.39%		-0.75%	+58.43%

May. 15	Transcript : PROCEPT BioRobotics Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 09:20 AM
May. 06	Piper Sandler Adjusts Price Target on PROCEPT BioRobotics to $75 From $67, Maintains Overweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Adjusts Price Target on PROCEPT BioRobotics to $75 From $67, Maintains Overweight Rating	May. 06	MT
Procept BioRobotics Insider Sold Shares Worth $1,200,000, According to a Recent SEC Filing	May. 06	MT
Procept BioRobotics Insider Sold Shares Worth $1,916,428, According to a Recent SEC Filing	May. 06	MT
Truist Raises PROCEPT BioRobotics' PT to $72 From $63 After 'Solid' Q1 Beat, Keeps Buy Rating	May. 02	MT
Procept Biorobotics Insider Sold Shares Worth $263,243, According to a Recent SEC Filing	Mar. 21	MT
Wells Fargo Adjusts Price Target on PROCEPT BioRobotics to $47 From $44, Maintains Overweight Rating	Jan. 09	MT
Truist Securities Raises Price Target on PROCEPT BioRobotics to $50 From $48, Maintains Buy Rating	Dec. 22	MT
Wells Fargo Raises Price Target on PROCEPT BioRobotics to $44 From $40, Maintains Overweight Rating	Dec. 13	MT
B. Riley Lowers PROCEPT BioRobotics' PT to $55 From $60 on Lower Multiple, Keeps Buy Rating	Nov. 02	MT
Piper Sandler Initiates PROCEPT BioRobotics at Overweight With $42 Price Target	23-08-11	MT
William Blair Initiates PROCEPT BioRobotics at Outperform Rating	23-05-31	MT
Truist Adjusts Price Target on PROCEPT BioRobotics to $49 From $54, Keeps Buy Rating	23-05-01	MT
KeyBanc Adjusts Price Target on PROCEPT BioRobotics to $47 From $48, Maintains Overweight Rating	23-05-01	MT
BofA Securities Adjusts PROCEPT BioRobotics' Price Target to $44 From $52, Keeps Buy Rating	23-04-28	MT
Truist Adjusts PROCEPT BioRobotics' Price Target to $49 From $54, Keeps Buy Rating	23-04-28	MT
Truist Securities Trims Price Target on PROCEPT BioRobotics to $55 From $58, Maintains Buy Rating	23-01-31	MT
Wells Fargo Adjusts Price Target on PROCEPT BioRobotics to $43 From $52, Maintains Overweight Rating	23-01-12	MT
Wells Fargo Adjusts Price Target on PROCEPT BioRobotics to $52 From $49, Maintains Overweight Rating	22-12-12	MT
Truist Securities Adjusts PROCEPT BioRobotics Price Target to $58 From $56, Maintains Buy Rating	22-11-14	MT
KeyBanc Capital Markets Adjusts Price Target on PROCEPT BioRobotics to $48 From $47, Maintains Overweight Rating	22-11-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. PROCEPT BioRobotics Corporation

Equities

PRCT

US74276L1052

Analyst Reco.

Filters